These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7872845)

  • 21. The treatment of tardive dyskinesia.
    Raja M
    Schweiz Arch Neurol Psychiatr (1985); 1996; 147(1):13-8. PubMed ID: 8685689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Discontinuation of neuroleptic treatment in patients with schizophrenia].
    Alagille M; Blondiaux I; Ginestet D
    Encephale; 1990; 16(2):125-31. PubMed ID: 1972052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stopping drug treatment in schizophrenia.
    Drug Ther Bull; 1987 Apr; 25(8):31-2. PubMed ID: 2884089
    [No Abstract]   [Full Text] [Related]  

  • 24. Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
    Davidson M; Kahn RS; Powchik P; Warne P; Losonczy MF; Kaminsky R; Apter S; Jaff S; Davis KL
    Arch Gen Psychiatry; 1991 Jan; 48(1):73-6. PubMed ID: 1670618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Placebo washout in trials of antipsychotic drugs.
    Volavka J; Cooper TB; Laska EM; Meisner M
    Schizophr Bull; 1996; 22(4):567-76. PubMed ID: 8938911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylphenidate challenge as a predictor of relapse in schizophrenia.
    Lieberman JA; Kane JM; Gadaleta D; Brenner R; Lesser MS; Kinon B
    Am J Psychiatry; 1984 May; 141(5):633-8. PubMed ID: 6143506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolactin shifts after neuroleptic withdrawal.
    Green AI; Faraone SV; Brown WA
    Psychiatry Res; 1990 Jun; 32(3):213-9. PubMed ID: 1975101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rebound insomnia in neuroleptic drug withdrawal neurophysiologic characteristics.
    van Sweden B
    Pharmacopsychiatry; 1987 May; 20(3):116-9. PubMed ID: 2885865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Research in schizophrenia and the discontinuation of antipsychotic medications.
    Wyatt RJ
    Schizophr Bull; 1997; 23(1):3-9. PubMed ID: 9050108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Withdrawal-emergent respiratory dyskinesia with risperidone treated with clozapine.
    Mendhekar DN; Inamdar A
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):E24. PubMed ID: 20463136
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term neuroleptic treatment of chronic schizophrenic patients: clinical and biochemical effects of withdrawal.
    Zander KJ; Fischer B; Zimmer R; Ackenheil M
    Psychopharmacology (Berl); 1981; 73(1):43-7. PubMed ID: 6112769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of relapse in schizophrenia.
    Lieberman JA; Kane JM; Sarantakos S; Gadaleta D; Woerner M; Alvir J; Ramos-Lorenzi J
    Arch Gen Psychiatry; 1987 Jul; 44(7):597-603. PubMed ID: 2886110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication.
    Glovinsky D; Kalogeras KT; Kirch DG; Suddath R; Wyatt RJ
    Schizophr Res; 1994 Feb; 11(3):273-6. PubMed ID: 7910756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paliperidone overdose in a patient with schizophrenia.
    Chang JP; Huang CC; Su KP
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):418. PubMed ID: 19995588
    [No Abstract]   [Full Text] [Related]  

  • 35. Neuroleptic-induced supersensitivity psychosis: retrospective study of schizophrenic inpatients.
    Hunt JI; Singh H; Simpson GM
    J Clin Psychiatry; 1988 Jul; 49(7):258-61. PubMed ID: 2899071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous versus intermittent neuroleptic therapy in schizophrenia.
    Jolley AG; Hirsch SR
    Drug Saf; 1993 May; 8(5):331-9. PubMed ID: 8099290
    [No Abstract]   [Full Text] [Related]  

  • 37. Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():21-6. PubMed ID: 10739327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptic malignant syndrome following levomepromazine discontinuation.
    Tanii H; Saka K; Inoue K; Okada M
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):E16. PubMed ID: 20463130
    [No Abstract]   [Full Text] [Related]  

  • 39. Managing clozapine discontinuation - acute and chronic maintenance strategies.
    Shields MK; Bastiampillai T; Mohan T
    Aust N Z J Psychiatry; 2012 Nov; 46(11):1104-5. PubMed ID: 23104931
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antiparkinson drugs in neuroleptic treatment: comparative study of progressive and abrupt withdrawal].
    Ben Hadj Ali B; Dogui M; Ben Ammou S; Lôo H
    Encephale; 1995; 21(3):209-15. PubMed ID: 7649071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.